Oncology Flashcards
(161 cards)
4 most common cancers?
Top 4 cancers with highest mortality?
Breast- Lung- CRC- Prostate
Lung- CRC- Breast- Prostate
Examples of uninterrupted oestrogen exposure increasing breast cancer risk
Late childbearing, Nullparity, Early menarche, Late menopause, Obesity, HRT
2 week referral guidelines for ?breast cancer
30+= Unexplained lump 50+= unilateral discharge/retraction/nipple sign
Consider if skin changes/ Axilla lump
If <30 + unexplained lumo then non-urgent referral
Describe breast cancer screening in the UK
50-70 years
Mammogram every 3 years
What is the breast cancer triple assessment?
What is added if there is a discrepancy?
1- Clinical Dx
2- Bilateral mammography
3- Targeted US biopsy (FNAC)
MRI
Isotopic bone scan or CT if ?Disseminated disease
What is triple -ve breast cancer?
ER -ve HER2 -ve and PR-ve
HARDER TO TREAT
When does BRCA1/2 status impact treatment?
if <50 and triple -ve
Broad indication for surgery in breast cancer?
Wen is neo-adjuvant chemo given?
Number one choice if localised
+/- Post op RT
+/- Neo-adjuvant Chemo if HER-2 +VE or Triple -ve or need to reduce size to enable surgery
How does ER/PR status impact prognosis in breast cancer?
Better if +ve
How does HER2 status impact prognosis in breast cancer?
Worse if +ve
In what breast cancer group is chemotherapy most effective in?
<50
+ Oncotype Dx can help predict extent of benefit
Tumour marker used in breast cancer?
CA15.3
When is RT required to treat breast cancer?
Following conservative surgery by all residual tissue to decrease recurrence
Post-mastectomy if high recurrence risk (mets or >4cm or deep resection margin)
When is endocrine therapy the primary treatment in breast cancer?
ER/PR +ve and slowly progressive
Indications for tamoxifen in breast cancer?
ER/PR +VE
PRE-MENOPAUSAL
taken for 5 years as adjuvant
Indications for Herceptin (Trastuzamab) in breast cancer?
HER2 +VE
12 months but need regular cardiac testing
Indications for Aromatase inhibitors (Anastrazole) in breast cancer?
What are the complications?
POST-MENOPAUSAL and ER/PR +VE
Osteoporotic events therefore do DEXA baseline
Median response to endocrine therapy if breast cancer with metastatic disease?
1-2 years
What factors are considered during management of metastatic breast cancer?
What is not part of the treatments for the above?
Extent, hormone status, HER2 status, symptoms, preferences, performance status
If mets or S4 post-assessment then surgery only has a palliative role. Metastatic solid breast cancer tumour= Wholly palliative.
Information and support available to breast cancer patients
Breast cancer nurse specialist
Psychological support
Lymphedema risk
Early menopause (iartrogenic)
What factors impact the response to endocrine therapy in breast cancer?
Dominant site of the disease- greater response if soft tissue; much reduced if bony or visc mets
An objective response to prior endocrine therapy
Greater duration of previous disease free interval
Most common type of prostate cancer?
Where in the prostate is cancer likely to be?
95% Adenocarcinoma
Peripheral or posterior (BPH likely centric)
Gold standard imaging of choice in ?Prostate cancer
MRI
What do patients with an abnormal PR usually get if ?Prostate cancer?
Transrectal biopsy under US guidance